|
FAQ
Detailed Search
|
| Topic: |
diabetes (dm) |
| Title: |
Educating Patients With Type 2 Diabetes on a New Class of Drug, Dipeptidyl Peptidase 4 Inhibitors. |
| Author: |
Siminerio, L. |
| Source: |
Diabetes Educator. 33(Suppl 5):111S-113S. May - June 2007. |
| Abstract: |
New and innovative antihyperglycemic therapies for people with type 2 diabetes have recently become available. This article is from a special supplement about an American Association of Diabetes Educators’ continuing education program called a Multidisciplinary Approach in Addressing Novel Mechanisms in the Management of Type 2 Diabetes, held in Los Angeles in August 2006. In this article, the author considers patient education approaches for people with type 2 diabetes who are being treated with dipeptidyl peptidase 4 (DPP-4) inhibitors. DPP-4 inhibitors, including sitagliptin and vildagliptin, can be given orally once a day and are not associated with an increased risk for hypoglycemia or weight gain. Patient adherence to any drug regimen remains a problem; reports show that adherence to oral medications ranges from 65 to 85 percent. The author briefly reviews some of the reasons for patient nonadherence and offers suggestions about how diabetes educators can be an active part of the diabetes patient care team. The patient with a good health care team, appropriate support, and adequate diabetes self-management education (DSME) is more likely to comply with drug regimens and prevent complications. 1 figure. 1 table. 8 references. |
| Format: |
Journal Article |
| Language: |
English. |
| Major Keywords: |
Diabetes Mellitus. Type 2 Diabetes. Patient Care Management. Drug Therapy. Patient Care Team. |
| Minor Keywords: |
Incretin Mimetics. Hyperglycemia. Drug Effects. Administration and Dosage. Patient Compliance. Self Care. Patient Education. |
| Publication Number: |
DMJA12974. |
| Printer-Friendly Version | Return to Search Results |
|
<-- previous record
|
next record -->
|
|
 |
|
